succinylacetone has been researched along with Cancer of Colon in 2 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, PJ | 1 |
| Woo, SJ | 1 |
| Yoo, HM | 1 |
| Cho, N | 1 |
| Kim, HP | 1 |
| Gederaas, OA | 1 |
| Rasch, MH | 1 |
| Berg, K | 1 |
| Lagerberg, JW | 1 |
| Dubbelman, TM | 1 |
2 other studies available for succinylacetone and Cancer of Colon
| Article | Year |
|---|---|
Differential Mechanism of ATP Production Occurs in Response to Succinylacetone in Colon Cancer Cells.
Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neop | 2019 |
Photodynamically induced effects in colon carcinoma cells (WiDr) by endogenous photosensitizers generated by incubation with 5-aminolaevulinic acid.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Biomarkers, Tumor; Colonic Neoplasms; Fluorescent Dyes; | 1999 |